Do low B12, low folate, high homocysteine, and high methylmalonic acid indicate impaired one-carbon metabolism?

One-carbon metabolism is a vital biochemical network, and its disruption by vitamin B12 or folate deficiency manifests through a highly specific profile of serum metabolites and hematologic markers.

Metabolic biomarkers and pathway mechanics

• High sensitivity of MMA and homocysteine: In patients with clinically established vitamin B12 deficiency, methylmalonic acid (MMA) is elevated in 98.4% of episodes and total homocysteine (tHcy) is elevated in 95.9% of episodes. Normal levels of both metabolites virtually exclude a functional deficiency.
• Enzymatic blockades: MMA accumulates specifically when the mitochondrial enzyme methylmalonyl-CoA mutase is impaired due to a lack of its cofactor, adenosyl-cobalamin. Concurrently, the remethylation of homocysteine to methionine requires both cobalamin and folate, making elevated tHcy a highly sensitive shared marker of both deficiencies.

Hematologic masking and folate interactions

• Thymidylate synthesis and macrocytosis: Macrocytosis (elevated mean corpuscular volume, or MCV) is a classic hematologic hallmark of megaloblastic anemia caused by B12 and folate deficiencies, which directly impair thymidylate synthesis and disrupt cell division.
• The folate masking effect: Adequate or high folate intake can correct these megaloblastic changes, leading to a normal MCV and masking the classic hematologic signs of B12 deficiency.
• Exacerbation of metabolic stress: High folate status interacts synergistically with low vitamin B12 levels to produce even more pronounced metabolic disturbances, worsening elevations in MMA and tHcy while leaving neurological and tissue-level impairment unchecked.

Bottom line

• The combination of low vitamin B12/folate, elevated MMA, and elevated homocysteine represents a biologically validated clinical pattern of impaired one-carbon metabolism, though clinicians must look beyond normal red blood cell indices as high folate status can mask macrocytosis while metabolic deficiency persists.